Lucy Graubard
Pediatrics · Houston, TXNPI 1639252984
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $544, 3.0 times the $182 reported in 2019. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $27.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$211
- Merck$168
- Cranial Technologies, Inc$168
- Organon$124
- Dermavant Sciences, Inc.$124
- Pfizer$110
- plus $729 from 19 others
What the payments were for
- Food & beverage$1,634100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 5 | $211 |
| Merck | 10 | $168 |
| Cranial Technologies, Inc | 11 | $168 |
| Organon | 1 | $124 |
| Dermavant Sciences, Inc. | 1 | $124 |
| Pfizer | 5 | $110 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| Kyowa Kirin, Inc. | 1 | $84 |
| Seqirus USA Inc | 4 | $80 |
| Phadia US Inc. | 2 | $44 |
| Sun Pharmaceutical Industries Inc. | 1 | $42 |
| GSK | 2 | $41 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| UCB, Inc. | 1 | $38 |
| Shire North American Group Inc | 2 | $37 |
| Genentech USA, Inc. | 2 | $32 |
| Biomarin Pharmaceutical Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca | 1 | $21 |
| Novartis | 1 | $20 |
| Coloplast | 1 | $20 |
| Sobi, Inc | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Tris Pharma Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,634 in reported general payments places this provider in the 90th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.